tirzepatide cas number 2023788-19-2 Tirzepatide Side Chain | Fmoc-Lys(tBuO-Ara-Glu(AEEA-AEEA)-OtBu)-OH

It contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, which works by mimicking a hormone that targets areas of the brain involved in appetite regulation

Approved by the MHRA and available on NHS prescription, Trulicity offers effective glycaemic control alongside potential cardiovascular benefits and modest weight management support when used as part of a comprehensive diabetes treatment plan

Work with your healthcare provider to develop a meal plan that supports both diabetes management and Retatrutide treatment

GHK-Cu skin improvements develop gradually over 6 to 12 weeks as collagen remodeling progresses